Treatment with pancreatic enzymes;Therapie mit pankreasenzymen

Deutsches Arzteblatt

Volumn 108, Issue 34-35, 2011, Pages 578-582

  Mössner, Joachim ^a   Keim, Volker ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PANCREAS ENZYME; PROTON PUMP INHIBITOR; TRIACYLGLYCEROL LIPASE; DRUG DOSAGE FORM; PANCREATIN;

CELIAC DISEASE; CHRONIC PANCREATITIS; CYSTIC FIBROSIS; DIARRHEA; ENZYME THERAPY; HUMAN; PANCREAS CANCER; PANCREAS SURGERY; REVIEW; STEATORRHEA; STOMACH ACID; DOSE RESPONSE; DRUG DOSAGE FORM; EXOCRINE PANCREATIC INSUFFICIENCY; PANCREAS FUNCTION TEST; PREDICTIVE VALUE;

DOSAGE FORMS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXOCRINE PANCREATIC INSUFFICIENCY; HUMANS; PANCREATIC FUNCTION TESTS; PANCREATIN; PREDICTIVE VALUE OF TESTS;

EID: 80054923223     PISSN: 00121207     EISSN: 01722107     Source Type: Journal    
DOI: 10.3238/arztebl.2011.0578     Document Type: Review

References (24)

1. Maljaars PW, Peters HP, Mela DJ, Masclee AA: Ileal brake: a sensible food target for appetite control. A review. Physiol Behav 2008; 95: 271-81.
2. Keim V, Klar E, Poll M, Schoenberg MH: Postoperative care following pancreatic surgery: surveillance and treatment. Dtsch Arztebl Int 2009; 106: 789-94.
3. Rosendahl J, Witt H, Szmola R, Bhatia E, Ózsvári B, Landt O, et al.: Chymotrypsin C (CTRC) alterations that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008; 40: 78-82.
4. Teich N, Mössner J: Hereditary pancreatitis. Best Pract Res Clin Gastroenterol 2008; 22: 115-30.
5. Ammann RW, Muellhaupt B, Meyenberger C, Heitz PU: Alcoholic nonprogressive chronic pancreatitis: prospective long-term study of a large cohort with alcoholic acute pancreatitis (1976-1992). Pancreas 1994; 9: 365-73. (Pubitemid 24116724)
6. Keim V, Witt H, Bauer N, Bödeker H, Rosendahl J, Teich N, Mössner J: The course of genetically determined chronic pancreatitis. JOP 2003; 4: 146-54. (Pubitemid 38963782)
7. DiMagno EP, Go VL, Summerskill WH: Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973; 288: 813-5.
8. Siegmund E, Löhr JM, Schuff-Werner P: The diagnostic validity of non-invasive pancreatic function tests - a meta-analysis. Z Gastroenterol 2004; 42: 1117-28. (Pubitemid 39486910)
9. Kampanis P, Ford L, Berg J: Development and validation of an improved test for the measurement of human faecal elastase-1. Ann Clin Biochem. 2009; 46: 33-7.
10. 13C breath tests for the assessment of exocrine pancreatic function. Pancreas 2010; 39: 955-9.
11. Lankisch PG, Dröge M, Hofses S, König H, Lembcke B: Steatorrhoea: you cannot trust your eyes when it comes to diagnosis. Lancet 1996; 347: 1620-1. (Pubitemid 26170884)
12. Teich N, Orth M, Keim V, Mössner J: Diagnostik von Pankreaserkrankungen, Bestimmung von Lipase und alpha-Amylase meistens verzichtbar. Dtsch Arztebl 2002; 99: A 2717-9.
13. Moolsintong P, Burton FR: Pancreatic function testing is best determined by the extended endoscopic collection technique. Pancreas 2008; 37: 418-21.
14. Bozkurt T, Braun U, Leferink S, Gilly G, Lux G: Comparison of pancreatic morphology and exocrine functional impairment in patients with chronic pancreatitis. Gut 1994; 35: 1132-6. (Pubitemid 24244273)
15. Pezzilli R: Chronic pancreatitis: maldigestion, intestinal ecology and intestinal inflammation. World J Gastroenterol 2009; 15: 1673-6.
16. Layer P, Keller J, Lankisch PG: Pancreatic enzyme replacement therapy. Curr Gastroenterol Reports 2001; 3: 101-8.
17. Löhr JM, Hummel FM, Pirilis KT, Steinkamp G, Körner A, Henniges F: Properties of different pancreatin preparations used in pancreatic exocrine insufficiency. Eur J Gastroenterol Hepatol 2009; 21: 1024-31.
18. Kühnelt P, Mundlos S, Adler G: Einfluss der Pelletgröße eines Pankreasenzympräparates auf die duodenale lipolytische Aktivität. Z Gastroenterol 1991; 29: 417-21.
19. Halm U, Löser C, Löhr M, Katschinski M, Mössner J: A double blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment Pharm Therap 1999; 13: 951-7. (Pubitemid 29312782)
20. Guarner L, Guarner F, Malagelada J-R: Fate of oral enzymes in pancreatic insufficiency. Gut 1993; 34: 708-12. (Pubitemid 23146902)
21. Suzuki A, Mizumoto A, Sarr MG, DiMagno EP: Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea? Gastroenterology 1997; 112: 2048-55. (Pubitemid 27240792)
22. Domínguez-Muñoz JE, Iglesias-García J, Iglesias-Rey M, Figueiras A, Vilariño-Insua M: Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Aliment Pharmacol Ther 2005; 21: 993-1000.
23. Caliari S, Benini L, Bonfante F, Brentegani MT, Fioretta A, Vantini I: Pancreatic extracts are necessary for the absorption of elemental and polymeric enteral diets in severe pancreatic insufficiency. Scand J Gastroenterol 1993; 28: 749-52. (Pubitemid 23232000)
24. Häusler M, Heimann G, Meilcke R, Biesterfeld S: Fibrosing colonopathy in an adult caused by over use of pancreatic enzyme supplements. Gut 2000; 47: 598.